Literature DB >> 27247468

Pentoxifylline as adjunct therapy to long-term clinical management of a right-to-left patent ductus arteriosus.

Elizabeth Turner1.   

Abstract

Management of a right-to-left ("reversed") patent ductus arteriosus (PDA) focuses on control of clinical signs associated with hyperviscosity due to erythrocytosis. Pentoxifylline therapy is presented as an adjunct to routine phlebotomies for the long-term clinical management of reversed PDA in a 10-year-old Chihuahua.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27247468      PMCID： PMC4866675     

Source DB:  PubMed          Journal:  Can Vet J        ISSN： 0008-5286            Impact factor:   1.008


  8 in total

1.  Reversed patent ductus arteriosus in a dog.

Authors:  M Arora
Journal:  Can Vet J       Date:  2001-06       Impact factor: 1.008

2.  Original investigation of right-to-left shunting patent ductus arteriosus in an Irish setter puppy.

Authors:  L Ferasin; F Rizzo; P G G Darke
Journal:  Vet J       Date:  2006-01-27       Impact factor: 2.688

3.  Successful closure of left-to-right patent ductus arteriosus in three dogs with concurrent pulmonary hypertension.

Authors:  Rachel L Seibert; Herbert W Maisenbacher; Robert Prosek; Darcy B Adin; Wendy G Arsenault; Amara H Estrada
Journal:  J Vet Cardiol       Date:  2010-02-25       Impact factor: 1.701

4.  Secondary polycythemia and seizures due to right to left shunting patent ductus arteriosus in a dog.

Authors:  A M Legendre; M D Appleford; G E Eyster; A W Dade
Journal:  J Am Vet Med Assoc       Date:  1974-06-15       Impact factor: 1.936

5.  Hydroxyurea for treatment of polycythemia secondary to right-to-left shunting patent ductus arteriosus in 4 dogs.

Authors:  K W Moore; R L Stepien
Journal:  J Vet Intern Med       Date:  2001 Jul-Aug       Impact factor: 3.333

6.  Long-term clinical management of right-to-left ("reversed") patent ductus arteriosus in 3 dogs.

Authors:  E Côté; S J Ettinger
Journal:  J Vet Intern Med       Date:  2001 Jan-Feb       Impact factor: 3.333

7.  Therapeutic response to pentoxifylline and its active metabolites in dogs with familial canine dermatomyositis.

Authors:  Christine A Rees; Dawn M Boothe
Journal:  Vet Ther       Date:  2003

Review 8.  Haemorheology and cerebrovascular disease: multifunctional approach with pentoxifylline.

Authors:  R Müller; F Lehrach
Journal:  Curr Med Res Opin       Date:  1981       Impact factor: 2.580
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.